Project Grant R56HL164477
Award Date
9/8/23
Completion Date
8/31/24
Dollars Obligated
$488K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
This federal Project Grant award of $2,251,975.00, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to identify unrecognized genetic causes of congenital heart disease (CHD). The award supports research with the following key objectives: Assessing the contribution of de novo non-coding variants of unknown significance (NCDNV) to unexplained CHD cases. Defining the contribution of rare coding region variants...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, supports research to interpret the impact of genetic variants, both coding and non-coding, on congenital heart disease (CHD). The $802,762 award to the University of Texas Southwestern Medical Center aims to define cardiac development gene regulatory networks and characterize how variants in these networks affect cardiomyocyte specification and...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837), supports a 5-year, $126,059 research project conducted by the University of Colorado-Denver. The project aims to utilize proximity extension assay technology to perform longitudinal proteomic analyses of children with congenital heart disease (CHD) in order to identify novel biomarkers and understand the systems biology underlying...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Disabilities Prevention Program (CFDA 93.184), provides $650,398 to Indiana University to advance nationwide surveillance of congenital heart defects (CHD). The project aims to: Employ methods to identify CHD cases among children, adolescents, and adults in Indiana using multiple data sources including birth registries, immunization records, and electronic health records. Integrate comprehensive...
This $2,087,677 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports research to investigate how the chromatin remodeling factor CHD7 regulates the development of cardiac and craniofacial lymphatic vessels. The primary grantee, Children's Hospital Los Angeles, will perform confocal and live imaging, lineage tracing, single-cell multiomics analysis, spatial transcriptomics, and...
This Project Grant award for $827,665 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837). The award aims to develop scalable methods to address key challenges in cardiovascular disease (CVD) genome-wide association studies. Specifically, the grant will fund research to: 1) identify causal genetic variants associated with CVD, 2) determine the most relevant cell types for these variants, and 3)...
This $596,401 Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research into the role of the long non-coding RNA MCRL1 in regulating human cardiac and hematopoietic differentiation. The research team at Indiana University Indianapolis aims to decipher the transcriptional and epigenetic mechanisms by which MCRL1 interacts with the signaling protein β-catenin to modulate mesoderm specification...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $817,208 Project Grant under the Cardiovascular Diseases Research Program (CFDA 93.837) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) to conduct research aimed at identifying novel genes and biological mechanisms underlying heart failure. The project will leverage high-throughput genomic and functional screening approaches, including cell painting and Perturb-seq assays, to systematically...
This federal Project Grant award of $179,280 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to address disparities in polygenic risk scores (PRS) for coronary heart disease (CHD) across diverse populations. The principal investigator, Dr. Tcheandjieu, will analyze genetic data from over 2.1 million individuals of European, African, Indigenous American, and Asian ancestries to explore population-specific differences...
This federal Project Grant award, valued at $1,399,182.00 and awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) on August 1, 2024, supports a comprehensive research study to investigate early-life risk factors and underlying mechanisms for the development of adult coronary heart disease (CHD). The primary objectives are to: 1) identify which small-for-gestational-age (SGA) infants are at elevated risk for later-life CHD and cardiovascular...